Sex: F
Vaccine: ANTH, ANTH
Symptoms: Pain, Pain in extremity
Clinical narrative: Leg weakness and extreme cramping; Lost use of leg over 3 months; Dercums disease (painful nodes with sporadic shooting pain); Fibromyalgia; Migraines; Asthma; Stomach issues; Right face numbness and pain; Right face numbness and pain; Extreme burning leg pain; Extreme burning leg pain; Leg weakness and extreme cramping; Stomach pain; Random shooting pain; Bouts of sudden nausea; Chronic fatigue; This case was retrieved from a VAERS download on 04MAR2022.  A 40-year-old female patient developed extreme burning leg pain (PT: Burning sensation and PT: Pain in extremity), "lost use of leg over 3 months" (PT: Movement disorder), leg weakness and extreme cramping (PT: Muscular weakness and PT: Muscle spasms), right face numbness and pain (PT: Hypoaesthesia and PT: Facial pain), stomach pain (PT: Abdominal pain upper), stomach issues (PT: Gastrointestinal disorder), bouts of sudden nausea (PT: Nausea), migraines (PT: Migraine), Dercums disease (painful nodes with sporadic shooting pain) (PT: Adiposis dolorosa), fibromyalgia (PT: Fibromyalgia), asthma (PT: Asthma), random shooting pain (PT: Pain) and chronic fatigue (PT: Fatigue) following the administration BioThrax (anthrax vaccine).  On 01JUL2007, the patient received BioThrax (dose: 6) via syringe. Lot number was unknown.  On 01AUG2007, the patient developed extreme burning leg pain, lost use of leg over 3 months, had leg weakness and extreme cramping while sitting, lying down and walking. The patient also developed right face numbness and pain, stomach pain, stomach issues, had bouts of sudden nausea, migraines, Dercum's disease (painful nodes with sporadic shooting pain), fibromyalgia, asthma, random shooting pain and chronic fatigue.  The action taken with BioThrax with respect to the reported events was not applicable.  The patient had not recovered from the reported events, at the time of this report.   The patient's medical history was reported as none. The current illness, allergies and concomitant medications were unknown.  Company comment: Although the report onset of these events stated that were about a month of receiving BioThrax, they are chronic in nature and possibly started before BioThrax vaccination. There may be other plausible contributing factors for the events experienced by the consumer and the causality of all the events is assessed as unlikely with BioThrax. The case is considered serious as permanent disability is reported as a seriousness criteria. Movement disorder, adiposis dolorosa, fibromyalgia, migraine, asthma, gastrointestinal disorder, hypoaesthesia, facial pain, muscular weakness, muscle spasms, and abdominal pain upper are unlisted whereas burning sensation, pain in extremity, pain, nausea, and fatigue are listed as per BioThrax.; Sender's Comments: Although the report onset of these events stated that were about a month of receiving BioThrax, they are chronic in nature and possibly started before BioThrax vaccination. There may be other plausible contributing factors for the events experienced by the consumer and the causality of all the events is assessed as unlikely with BioThrax. The case is considered serious as permanent disability is reported as a seriousness criteria. Movement disorder, adiposis dolorosa, fibromyalgia, migraine, asthma, gastrointestinal disorder, hypoaesthesia, facial pain, muscular weakness, muscle spasms, and abdominal pain upper are unlisted whereas burning sensation, pain in extremity, pain, nausea, and fatigue are listed as per BioThrax.